Amphastar Pharmaceuticals Inc expected to post earnings of 18  cents a share - Earnings Preview

Amphastar Pharmaceuticals,

04/05/2021 22:35

* Amphastar Pharmaceuticals Inc  AMPH.OQ   AMPH.O  is expected
to show a rise in quarterly revenue when it reports results on
May 6.
* The Rancho Cucamonga, California-based company is expected to
report   a 14.8% increase in revenue to $97.262 million from
$84.69 million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data.
​* Refinitiv's mean analyst estimate for Amphastar
Pharmaceuticals Inc is for earnings of 18 cents per share. For
the same quarter last year, the company reported earnings of 17
cents per share.
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 2 "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Amphastar
Pharmaceuticals Inc is $20​, about 12.6% above​ its last closing
price of $17.49. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020              0.14       0.16      Beat    16.7
 Sep. 30 2020  0.15        0.14       0.15      Beat    6.8
 Jun. 30 2020  0.14        0.14       0.16      Beat    17.9​
 Mar. 31 2020  0.08        0.09       0.17      Beat    97.7
 Dec.          -0.01​      0.07       0.07      Met     -5.6​
 31​ 2019​                                              
 Sep. 30 2019  0.07        0.07       0.10      Beat    49.6​
 Jun. 30 2019  0.06        0.03       0.08      Beat    134.1
 Mar. 31 2019  0.05        0.04       0.10      Beat    150
 This summary was machine generated May 4 at 21:35 GMT.  All
figures in US dollars unless otherwise stated